Logo
Register Log in
FirstArticle-BlurbImagePath
Endohepatology: Where Can EUS Take Us?

AUGUST 22, 2025

FirstArticle-BlurbImagePath
AGA Accepting Applications for Its Inaugural Incubator Program

AUGUST 21, 2025

FirstArticle-BlurbImagePath
Wegovy Approved to Treat MASH With Moderate to Advanced Fibrosis

AUGUST 20, 2025

Email This Article
POSTED: DECEMBER 6, 2024

FDA Grants Accelerated Approval to Bizengri for Pancreatic Adenocarcinoma and NSCLC

The FDA granted accelerated approval to zenocutuzumab for adults with advanced, unresectable or metastatic pancreatic adenocarcinoma.


A link to this article will be included in this email.
Recipient's Email Address:
Enter email addresses separated by commas if sending to more than one person. (200 characters max)
Your Name:
Your Email Address:


Personal Message: (Optional)
These email addresses will only be used to send out this message.
Please wait.. Please wait..

Pancreatic Disease

DECEMBER 6, 2024

FDA Grants Accelerated Approval to Bizengri for Pancreatic Adenocarcinoma and NSCLC


Related Content

Large Analysis Finds No Need for 5-FU Bolus in Some GI Cancer Regimens

Omitting a bolus of 5-FU as part of a FOLFOX, FOLFIRI


To read the full story, Log in or Sign up for a Free Account

Log in / Sign up

Check out our new Clinical tab!

We've added an exciting new feature to our website. Click on "Clinical" in the navbar to explore!

The following result is from the NPI Registry Public Search database. You can click on the NPI number to view detailed information and verify its accuracy. If your NPI is not found in this search, you can try searching again using the form below. If you have difficulty finding your NPI number please contact us at web@mcmahonmed.com
OR

NPI Name Organization/ Institution State Zip Code Taxonomy    Credential Select